5-Amino-1-methylquinolinium (5-Amino-1MQ) is a small molecule belonging to the class of methylquinolinium derivatives, characterized structurally by a quinolinium core substituted with an amino group at the 5-position and a methyl group at the 1-position.
It is recognized for its potent and selective inhibition of nicotinamide N-methyltransferase (NNMT), an enzyme implicated in a variety of metabolic and oncogenic processes.
Mechanisms of Action
5-Amino-1MQ acts predominantly by inhibiting NNMT, thereby influencing several interconnected metabolic, redox, and epigenetic pathways. NNMT plays a crucial role in the methylation of nicotinamide, affecting intracellular nicotinamide adenine dinucleotide (NAD+) metabolism—a key cellular cofactor for redox reactions, DNA repair, and transcriptional regulation.1
In preclinical studies, treatment of mouse adipocytes with 5-Amino-1MQ resulted in a concentration-dependent increase in NAD+ levels (approximately 1.2 to 1.6-fold higher than controls), which is significant for metabolic homeostasis and cellular health.1
Furthermore, the inhibition of NNMT by 5-Amino-1MQ impacts histone methylation, thereby modulating gene expression programs underlying metabolism and oncogenesis.2
Metabolic and Anti-Obesity Efficacy
In the context of metabolic health disorders, particularly obesity and related syndromes, 5-Amino-1MQ demonstrates remarkable efficacy.3 In diet-induced obesity mouse models, administration of 5-Amino-1MQ led to notable reductions in body weight, white adipose tissue mass, and adipocyte size, without observable adverse effects or changes in food intake.4
This implies its anti-obesity action does not arise from appetite suppression but rather from a direct metabolic modulation mechanism—namely, the suppression of lipogenesis (fat creation).3
These findings highlight the promise of 5-Amino-1MQ as a potential research compound for obesity and possibly type 2 diabetes.4
Applications in Cancer Therapy
Beyond metabolic disease, 5-Amino-1MQ has been explored extensively in preclinical oncology research. Its anticancer activity stems from two principal mechanisms: epigenetic remodeling via altered histone methylation, and direct modulation of cellular energetics and proliferation.2
Studies have shown that, in cancer-associated fibroblasts (CAFs), treatment with 5-Amino-1MQ not only modifies histone methylation patterns but also suppresses tumor-supportive metabolic functions. When applied in animal models, 5-Amino-1MQ has demonstrated the capacity to reduce tumor cell proliferation and alter the tumor microenvironment in favor of therapeutic intervention.2
These dual effects position it as a potential research candidate for both monotherapy and combination strategies in gynecological and potentially other malignancies.
Pharmacokinetics and Pharmacodynamics
While 5-Amino-1MQ exhibits strong biological activity and therapeutic promise, optimization of its pharmacokinetic and pharmacodynamic profiles remains a focus of ongoing research. Its effective cellular permeability and membrane passage have already been demonstrated, which supports its use across a variety of tissue types.3
Further in vitro studies are needed to refine aspects such as tissue-specific targeting, metabolic stability, and elimination, with the aim of maximizing clinical potential and minimizing off-target effects.
References
- Conlon, N., & Ford, D. (2022). A systems-approach to NAD+ restoration.. Biochemical pharmacology, 114946 . https://doi.org/10.1016/j.bcp.2022.114946.
- Myong, S., Nguyen, A., & Challa, S. (2024). Biological Functions and Therapeutic Potential of NAD+ Metabolism in Gynecological Cancers. Cancers, 16. https://doi.org/10.3390/cancers16173085.
- Li, X., Pi, Y., Chen, Y., Zhu, Q., & Xia, B. (2022). Nicotinamide N-Methyltransferase: A Promising Biomarker and Target for Human Cancer Therapy. Frontiers in Oncology, 12. https://doi.org/10.3389/fonc.2022.894744.
- Liu, J., Deng, Z., Zhu, X., Zeng, Y., Guan, X., & Li, J. (2021). Roles of Nicotinamide N-Methyltransferase in Obesity and Type 2 Diabetes. BioMed Research International, 2021. https://doi.org/10.1155/2021/9924314.
